The Giant at the Intersection of AI, Networking and Software
Broadcom isn’t just another chipmaker riding the semiconductor cycle, it’s a carefully assembled portfolio of some of the stickiest, most profitable businesses in tech.
At its core, Broadcom has mastered the art of acquisition, folding niche leaders into its empire, stripping out inefficiencies, and using the resulting free cash flow to fuel dividends,
» Read more about: The Giant at the Intersection of AI, Networking and Software »
Read More
Can You Retire On UPS?
United Parcel Service has long been one of the world’s most trusted shipping giants, a backbone of global commerce that seems almost untouchable. But in the past half decade, shareholders have felt more turbulence than smooth sailing. The stock is down 46%.
That’s a sobering reality for a company many once viewed as a safe,
» Read more about: Can You Retire On UPS? »
Read More
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read More
1 Signal That Dutch Bros Could Be a Monster Stock
If you gave up on Dutch Bros after its post-IPO slump, you might be kicking yourself right now. After going public in 2021 and fizzling out soon after, Dutch Bros has staged a remarkable comeback, rising nearly 90% over the past 2 years.
And this rebound isn’t just a flash in the pan.
» Read more about: 1 Signal That Dutch Bros Could Be a Monster Stock »
Read More
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read MoreThe Ivy
1 Science Powerhouse To Own for the Next Decade
Thermo Fisher Scientific has a knack for thriving even in challenging markets. While the company isn’t entirely immune to today’s global headwinds, slower biopharmaceutical spending, tighter budgets in academic labs, and muted demand in China, it has weathered the storm far better than most of its peers.
The reason?
A combination of unmatched scale,
» Read more about: 1 Science Powerhouse To Own for the Next Decade »
Read MoreThe Spotlight
Could Lemonade’s AI Insurance Engine Turn $1 Billion Into $10 Billion
After months of market jitters, earnings season has brought a wave of upbeat results, and stocks tied to improving outlooks are rallying hard.
Many investors who sat on the sidelines during the downturn are now realizing they may have missed some exceptional entry points.
But the best opportunities are about finding businesses with a runway long enough to turn today’s price into tomorrow’s fortune.
» Read more about: Could Lemonade’s AI Insurance Engine Turn $1 Billion Into $10 Billion »
Read MoreThe Daily
Dow edges higher as Home Depot puts focus on retail earnings
By Johann M Cherian and Sanchayaita Roy
(Reuters) – The blue-chip Dow was just shy of a record high on Tuesday as Home Depot shares gained after the retailer kept its annual forecasts intact,
» Read more about: Dow edges higher as Home Depot puts focus on retail earnings »